Details for Patent: 7,671,032

✉ Email this page to a colleague

Which drugs does patent 7,671,032 protect, and when does it expire?

Patent 7,671,032 protects OLYSIO and is included in one NDA.

This patent has seventy-six patent family members in thirty-four countries.

Summary for Patent: 7,671,032

Title:	HCV NS-3 serine protease inhibitors
Abstract:	Peptidomimetic compounds are described which inhibit the NS3 protease of the hepatitis C virus (HCV). The compounds have the formula where the variable definitions are as provided in the specification. The compounds comprise a carbocyclic P2 unit in conjunction with a novel linkage to those portions of the inhibitor more distal to the nominal cleavage site of the native substrate, which linkage reverses the orientation of peptidic bonds on the distal side relative to those proximal to the cleavage site. ##STR00001##
Inventor(s):	Rosenquist; Asa (Huddinge, SE), Thorstensson; Fredrik (Linkoping, SE), Johansson; Per-Ola (Linkoping, SE), Kvarnstrom; Ingemar (Linkoping, SE), Samuelsson; Bertil (Huddinge, SE), Wallberg; Hans (Huddinge, SE)
Assignee:	Medivir AB (Huddinge, SE)
Application Number:	10/572,349
Patent Claim Types: see list of patent claims	Compound; Composition;

Drugs Protected by US Patent 7,671,032

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Janssen Prods	OLYSIO	simeprevir sodium	CAPSULE;ORAL	205123-001	Nov 22, 2013		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 7,671,032

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Sweden	0400199	Jan 30, 2004
Sweden	0401288	May 19, 2004
Sweden	0402562	Oct 22, 2004

PCT Information
PCT Filed	January 28, 2005	PCT Application Number:	PCT/SE2005/000097
PCT Publication Date:	August 11, 2005	PCT Publication Number:	WO2005/073195

International Family Members for US Patent 7,671,032

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1713823	⤷ Sign Up	C300703	Netherlands	⤷ Sign Up
European Patent Office	1713823	⤷ Sign Up	CA 2014 00059	Denmark	⤷ Sign Up
European Patent Office	1713823	⤷ Sign Up	1490064-1	Sweden	⤷ Sign Up
European Patent Office	1713823	⤷ Sign Up	92595	Luxembourg	⤷ Sign Up
European Patent Office	1713823	⤷ Sign Up	300703	Netherlands	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.